Lake Street Capital Cuts Lakeland Industries (NASDAQ:LAKE) Price Target to $16.00

Lakeland Industries (NASDAQ:LAKE) had its price target reduced by Lake Street Capital from $19.00 to $16.00 in a research note published on Thursday,Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock.

Several other research analysts have also commented on the company. Weiss Ratings reissued a “sell (d)” rating on shares of Lakeland Industries in a research report on Thursday, January 22nd. Wall Street Zen downgraded Lakeland Industries from a “hold” rating to a “strong sell” rating in a research report on Saturday, December 13th. UBS Group set a $14.00 target price on Lakeland Industries in a research note on Wednesday, December 10th. Zacks Research upgraded Lakeland Industries from a “strong sell” rating to a “hold” rating in a report on Monday, February 9th. Finally, Roth Mkm reduced their price target on Lakeland Industries from $27.00 to $19.00 and set a “buy” rating on the stock in a research report on Wednesday, December 10th. Two equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Lakeland Industries currently has an average rating of “Hold” and a consensus price target of $15.75.

Lakeland Industries Price Performance

Shares of NASDAQ:LAKE opened at $8.47 on Thursday. Lakeland Industries has a one year low of $7.15 and a one year high of $20.50. The company has a 50-day simple moving average of $8.96 and a 200-day simple moving average of $11.71. The stock has a market capitalization of $83.09 million, a price-to-earnings ratio of -1.93 and a beta of 1.34. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.48 and a current ratio of 3.83.

Hedge Funds Weigh In On Lakeland Industries

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. BNP Paribas Financial Markets grew its stake in shares of Lakeland Industries by 87.8% during the third quarter. BNP Paribas Financial Markets now owns 1,795 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 839 shares in the last quarter. Tripletail Wealth Management LLC acquired a new position in shares of Lakeland Industries in the third quarter worth about $49,000. Bank of America Corp DE lifted its stake in shares of Lakeland Industries by 189.9% in the second quarter. Bank of America Corp DE now owns 4,177 shares of the medical instruments supplier’s stock worth $57,000 after acquiring an additional 2,736 shares in the last quarter. JPMorgan Chase & Co. purchased a new position in Lakeland Industries in the second quarter valued at about $59,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in Lakeland Industries during the 2nd quarter valued at approximately $68,000. 71.69% of the stock is owned by hedge funds and other institutional investors.

Lakeland Industries News Roundup

Here are the key news stories impacting Lakeland Industries this week:

• Neutral Sentiment: Lake Street Capital cut its price target on LAKE from $19.00 to $16.00 but kept a “buy” rating — a downward revision to expectations but still a constructive view on longer‑term upside. Read More.
• Negative Sentiment: Pomerantz filed an official class action in the Southern District of New York alleging securities‑law violations for purchases between Dec. 1, 2023 and Dec. 9, 2025 — this formal complaint can lead to discovery, damages exposure and management distraction. Read More.
• Negative Sentiment: Multiple plaintiff firms (Faruqi & Faruqi, Robbins LLP, Rosen Law, Frank R. Cruz, Kirby McInerney and others) have issued investor notices and are soliciting lead plaintiffs ahead of an April 24, 2026 deadline — a cluster of suits/claims increases the probability of consolidated litigation and potential settlement/defense costs. Read More.

About Lakeland Industries

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.